Literature DB >> 28844752

Multifocal iris melanoma in a 2-year-old managed with I-125 plaque brachytherapy.

Andrew R Lee1, Dilraj S Grewal1, Thomas J Cummings2, Laura B Enyedi1, Nicole A Larrier3, Prithvi Mruthyunjaya4.   

Abstract

We report a 23-month-old patient presenting with multifocal iris melanoma who underwent plaque brachytherapy with full corneal coverage. The lesion demonstrated several high-risk clinical and histopathologic features associated with iris melanoma in adults, including growth and angle seeding. The patient has been subsequently followed for 3.5 years with no evidence of recurrence. This report demonstrates the importance of serial examination of suspected melanocytic iris lesions in very young children and the effective treatment option of globe-sparing radiation therapy.
Copyright © 2017 American Association for Pediatric Ophthalmology and Strabismus. Published by Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2017        PMID: 28844752     DOI: 10.1016/j.jaapos.2017.03.014

Source DB:  PubMed          Journal:  J AAPOS        ISSN: 1091-8531            Impact factor:   1.220


  1 in total

1.  Palladium-103 plaque therapy for multifocal iris melanoma: Radiation of the entire anterior segment of the eye.

Authors:  Paul T Finger; Ankit Singh Tomar; Kimberly J Chin
Journal:  Eur J Ophthalmol       Date:  2020-04-20       Impact factor: 2.597

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.